Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 3, Pages 790
Publisher
MDPI AG
Online
2022-02-05
DOI
10.3390/cancers14030790
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)
- (2021) Shankar Siva et al. JAMA Oncology
- Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer
- (2021) Gregory M.M. Videtic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
- (2020) Robert Olson et al. BMC CANCER
- Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic
- (2020) C. Faivre-Finn et al. CLINICAL ONCOLOGY
- Oncology Practice During the COVID-19 Pandemic
- (2020) Deborah Schrag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
- (2020) Matthias Guckenberger et al. RADIOTHERAPY AND ONCOLOGY
- Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development
- (2020) David J. Thomson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
- (2020) David A. Palma et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-fraction SBRT for Early Stage NSCLC-A Viable Option in “These Uncertain Times”?
- (2020) Joseph K. Salama et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
- (2019) Percy Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
- (2019) David A Palma et al. LANCET
- Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
- (2019) David A. Palma et al. BMC CANCER
- One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial
- (2019) Anurag K. Singh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non–Small-cell Lung Cancer
- (2018) Sung Jun Ma et al. Clinical Lung Cancer
- Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non–Small-Cell Lung Cancer: A Two-Institution Propensity Score–Matched Analysis
- (2018) Sung Jun Ma et al. Clinical Lung Cancer
- SUNSET: Stereotactic Radiation for Ultracentral Non–Small-Cell Lung Cancer—A Safety and Efficacy Trial
- (2018) Meredith Giuliani et al. Clinical Lung Cancer
- Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non–small-cell Lung Cancer: A Two-institution Propensity-matched Analysis
- (2018) Michael A. Cummings et al. Clinical Lung Cancer
- Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
- (2018) Feng-Ming (Spring) Kong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer
- (2018) Gregory M. Videtic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors
- (2017) Younghee Park et al. Radiation Oncology
- Stereotactic Ablative Body Radiotherapy for Lung Metastases: Where is the Evidence and What are We Doing With It?
- (2017) Shankar Siva et al. SEMINARS IN RADIATION ONCOLOGY
- Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience
- (2015) Karin Lindberg et al. ACTA ONCOLOGICA
- Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy
- (2015) Naomi E. Verstegen et al. Journal of Thoracic Oncology
- Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54–56 Gy given in 9–7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size
- (2015) Masahiko Aoki et al. Radiation Oncology
- Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors
- (2013) Atsushi Nambu et al. BMC CANCER
- Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
- (2013) Mojgan Taremi et al. Radiation Oncology
- Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases
- (2013) Andrea R. Filippi et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Radiation-Induced Rib Fractures After Hypofractionated Stereotactic Body Radiation Therapy: Risk Factors and Dose–Volume Relationship
- (2012) Kaori Asai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States
- (2012) Megan E. Daly et al. Journal of Thoracic Oncology
- Prediction of Chest Wall Toxicity From Lung Stereotactic Body Radiotherapy (SBRT)
- (2011) Kevin L. Stephans et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer
- (2011) Eva M. Bongers et al. Journal of Thoracic Oncology
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- (2010) Robert Timmerman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
- (2009) Achilles J. Fakiris et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Only Half of the Chronic Pain After Thoracic Surgery Shows a Neuropathic Component
- (2008) Monique A.H. Steegers et al. JOURNAL OF PAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now